3rd Parties Again Denied Class Cert. In Neurontin Suit

Law360, New York (May 15, 2009, 12:00 AM EDT) -- Fearing a “tsunami” of trials, a judge has denied a renewed request to certify a class of third-party payers in a suit against Pfizer Inc. and Warner-Lambert Co. over alleged promotion of the epilepsy drug Neurontin for off-label uses such as restless legs syndrome.

Judge Patti B. Saris of the U.S. District Court for the District of Massachusetts issued the order Wednesday in multidistrict litigation involving the drugmakers’ alleged illegal campaign to increase profits from the drug by encouraging doctors to prescribe it for a variety...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.